News & Events
Magstim Welcomes EGI
Magstim Acquires Electrical Geodesics, Inc. (EGI) Product Portfolio High-density EEG complements Magstim’s Transcranial Magnetic Stimulation Technology Driving Innovation Study of Brain MINNEAPOLIS, Minn. & Carmarthenshire, UK -- (July 2, 2020) – Magstim, the global leader in Transcranial Magnetic Stimulation (TMS),…
Rhythm and Acceleration in TMS – Magstim Academy June 11th
Magstim Academy Lecture Series – Rhythm and Acceleration - recent advances in TMS treatment for mood disorders. Mark George, MD, Nolan Williams, MD and Martijn Arns, PhD will present on their recently published and on-going TMS studies.
Magstim Academy Lecture Series
Magstim Academy Lecture Series – this live series will begin on May 12th and cover cutting-edge magnetic stimulation research.
Message from our CEO
My team would like to thank all the TMS clinicians and treaters who continue to provide life-changing TMS treatments safely to their patients during the COVID-19 crisis. We recognize your dedication and we are here to support you every step…
Provider Spotlight
In accordance with guidelines recommended by the CDC and other health organizations, many TMS treatment clinics are still operational. This is an example of a TMS center that continues to operate and support both existing and new patients.
First clinical TMS navigation system receives 510k clearance
Magstim® TMS has launched the very first Transcranial Magnetic Stimulation navigation system specifically developed for the clinical market.
How Does TMS Work?
In depressed patients, electrical activity in certain areas of the brain is reduced. Watch our video about what Magstim Trancranial Magnetic Stimulation (TMS) is and how it works to combat depression.
TMS patient calls for better understanding of depression treatment options
A 34 year old man, who suffered from depression for 20 years and endured 13 courses of antidepressants with no effect, is calling for greater awareness of a non-invasive treatment that treats depression with magnetic pulses to stimulate brain activity.
Magstim TMS receives FDA clearance for 3- minute theta burst treatment
Magstim has received FDA clearance to include intermittent Theta Burst Stimulation (iTBS) as a treatment for Major Depressive Disorder with its Horizon® TMS Therapy systems.Keep up to date
By signing up you are confirming that you have read, understood and accept our Privacy Policy
